scholarly article | Q13442814 |
P50 | author | Kaumudi Joshipura | Q39973811 |
P2093 | author name string | Cynthia M Pérez | |
Francisco J Muñoz-Torres | |||
José L Vergara | |||
Oelisoa M Andriankaja | |||
James J Jiménez | |||
P2860 | cites work | The influence of anti-infective periodontal treatment on C-reactive protein: a systematic review and meta-analysis of randomized controlled trials | Q26853062 |
Inflammatory mechanisms linking periodontal diseases to cardiovascular diseases | Q26997381 | ||
Obesity and periodontitis: systematic review and meta-analysis. | Q27692127 | ||
Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study | Q28186001 | ||
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health | Q28288766 | ||
Obesity: preventing and managing the global epidemic. Report of a WHO consultation | Q29547404 | ||
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein | Q29547752 | ||
Relationship between gingival bleeding and anaerobic periodontal infection assessed by BANA (N-Benzoyl-DL-Arginine-β-Napthylamide) assay | Q34147395 | ||
Acute-phase reactants in infections and inflammatory diseases. | Q34200615 | ||
Determinants of C-reactive protein concentration in blood. | Q34220866 | ||
Clinical application of C-reactive protein for cardiovascular disease detection and prevention | Q35054464 | ||
Relative utility of 1-h Oral Glucose Tolerance Test as a measure of abnormal glucose homeostasis. | Q35165278 | ||
A review of C-reactive protein: A diagnostic indicator in periodontal medicine | Q36307545 | ||
Risk assessment and management of periodontal disease | Q36621268 | ||
Statin use is associated with fewer periodontal lesions: A retrospective study | Q36688456 | ||
Case definitions for use in population-based surveillance of periodontitis | Q36869291 | ||
Lifestyle intervention and/or statins for the reduction of C-reactive protein in type 2 diabetes: from the look AHEAD study | Q36947413 | ||
Association of progranulin and high sensitivity CRP concentrations in gingival crevicular fluid and serum in chronic periodontitis subjects with and without obesity | Q37262035 | ||
Predictors of improvement in cardiometabolic risk factors with weight loss in women | Q37457793 | ||
Potential association between prediabetic conditions and gingival and/or periodontal inflammation | Q37693820 | ||
Periodontitis and type II diabetes: a two-way relationship | Q38168269 | ||
The role of adipose tissue immune cells in obesity and low-grade inflammation. | Q38227543 | ||
Relationship of destructive periodontal disease to the acute-phase response | Q39658010 | ||
Effect of atorvastatin on chronic periodontitis: a randomized pilot study | Q39949599 | ||
Representativeness of the "Ramfjord teeth" for epidemiologic studies of gingivitis and periodontitis | Q41318195 | ||
Clinical effect of subgingivally delivered simvastatin in the treatment of patients with chronic periodontitis: a randomized clinical trial | Q43164031 | ||
Tooth loss, periodontitis, and statins in a population-based follow-up study | Q44012981 | ||
High-dose atorvastatin reduces periodontal inflammation: a novel pleiotropic effect of statins. | Q44804684 | ||
Pooled analyses of effects on C-reactive protein and low density lipoprotein cholesterol in placebo-controlled trials of ezetimibe monotherapy or ezetimibe added to baseline statin therapy | Q46149596 | ||
Statin therapy decreases serum levels of high-sensitivity C-reactive protein and tumor necrosis factor-α in HIV-infected patients treated with ritonavir-boosted protease inhibitors | Q47754842 | ||
Temporal association of elevated C-reactive protein and periodontal disease in men. | Q47909748 | ||
Acute-phase inflammatory response to periodontal disease in the US population. | Q54013888 | ||
Update of the case definitions for population-based surveillance of periodontitis. | Q55363466 | ||
Effect of statin and fibrate treatment on inflammation in type 2 diabetes. A randomized, cross-over study | Q61738106 | ||
Relationship of "bleeding on probing" and "gingival index bleeding" as clinical parameters of gingival inflammation. | Q64934272 | ||
Effects of ezetimibe on markers of synthesis and absorption of cholesterol in high-risk patients with elevated C-reactive protein | Q86422402 | ||
Clinical efficacy of subgingivally delivered 1.2% atorvastatin in chronic periodontitis: a randomized controlled clinical trial | Q87403401 | ||
Periodontitis in coronary heart disease patients: strong association between bleeding on probing and systemic biomarkers | Q88113761 | ||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | obesity | Q12174 |
P304 | page(s) | 1090-1096 | |
P577 | publication date | 2015-09-26 | |
P1433 | published in | Journal of Clinical Periodontology | Q15638559 |
P1476 | title | Lipid-lowering agents use and systemic and oral inflammation in overweight or obese adult Puerto Ricans: the San Juan Overweight Adults Longitudinal Study (SOALS). | |
P478 | volume | 42 |
Q52665346 | Association of marijuana use with oral HPV infection and periodontitis among Hispanic adults: Implications for oral cancer prevention. |
Q40423676 | Cross-sectional associations of impaired glucose metabolism measures with bleeding on probing and periodontitis |
Q55411987 | Insulin resistance predicts the risk of gingival/periodontal inflammation. |
Q47682042 | Over-the-counter mouthwash use and risk of pre-diabetes/diabetes. |
Q38983264 | Validation of two point-of-care tests against standard lab measures of NO in saliva and in serum |
Search more.